Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 35 citing articles:

RETRACTED ARTICLE: m6A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis
Dan Jin, Jiwei Guo, Yan Wu, et al.
Journal of Hematology & Oncology (2019) Vol. 12, Iss. 1
Open Access | Times Cited: 402
UBE2C Is Upregulated by Estrogen and Promotes Epithelial–Mesenchymal Transition via p53 in Endometrial Cancer
Yan Liu, Rong Zhao, Shuqi Chi, et al.
Molecular Cancer Research (2019) Vol. 18, Iss. 2, pp. 204-215
Open Access | Times Cited: 98
UBE2T promotes radiation resistance in non-small cell lung cancer via inducing epithelial-mesenchymal transition and the ubiquitination-mediated FOXO1 degradation
Hang Yin, Xiaoyuan Wang, Xue Zhang, et al.
Cancer Letters (2020) Vol. 494, pp. 121-131
Closed Access | Times Cited: 78
CDK1 serves as a therapeutic target of adrenocortical carcinoma via regulating epithelial–mesenchymal transition, G2/M phase transition, and PANoptosis
Liwen Ren, Yihui Yang, Wan Li, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 70
CDK4/6 inhibition blocks cancer metastasis through a USP51-ZEB1-dependent deubiquitination mechanism
Zhen Zhang, Jianjun Li, Yang Ou, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 62
Depletion of UBE2C reduces ovarian cancer malignancy and reverses cisplatin resistance via downregulating CDK1
Jiajia Li, Xiuling Zhi, Xiaoqing Shen, et al.
Biochemical and Biophysical Research Communications (2019) Vol. 523, Iss. 2, pp. 434-440
Closed Access | Times Cited: 47
Aberrant DNA methylation results in altered gene expression in non-alcoholic steatohepatitis-related hepatocellular carcinomas
Ying Tian, Eri Arai, Satomi Makiuchi, et al.
Journal of Cancer Research and Clinical Oncology (2020) Vol. 146, Iss. 10, pp. 2461-2477
Open Access | Times Cited: 44
MiR-525-5p Repressed Metastasis and Anoikis Resistance in Cervical Cancer via Blocking UBE2C/ZEB1/2 Signal Axis
Mei Chen, Lixiu Liu
Digestive Diseases and Sciences (2019) Vol. 65, Iss. 8, pp. 2442-2451
Closed Access | Times Cited: 43
Comprehensive Pan-Cancer Analysis of the Prognostic and Immunological Roles of the METTL3/lncRNA-SNHG1/miRNA-140-3p/UBE2C Axis
Xiulin Jiang, Yixiao Yuan, Lin Tang, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 38
UBE2C affects breast cancer proliferation through the AKT/mTOR signaling pathway
Zinan Lu, Jia Song, Tong-Hui Sun, et al.
Chinese Medical Journal (2021) Vol. 134, Iss. 20, pp. 2465-2474
Open Access | Times Cited: 36
Ubiquitin-conjugating enzyme 2C (UBE2C) is a poor prognostic biomarker in invasive breast cancer
Yousif A. Kariri, Michael S. Toss, Mansour Alsaleem, et al.
Breast Cancer Research and Treatment (2022) Vol. 192, Iss. 3, pp. 529-539
Open Access | Times Cited: 23
The Molecular Basis of Ubiquitin-Conjugating Enzymes (E2s) as a Potential Target for Cancer Therapy
Xiaodi Du, Hongyu Song, Nengxing Shen, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 7, pp. 3440-3440
Open Access | Times Cited: 26
The Impact of Non-coding RNAs in the Epithelial to Mesenchymal Transition
Bashdar Mahmud Hussen, Hamed Shoorei, Mahdi Mohaqiq, et al.
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 25
To be or not to be: navigating the influence of MicroRNAs on cervical cancer cell death
Mohammad Taghizadieh, Mina Kalantari, Roksana Bakhshali, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
Identification and Integrated Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer
Xingyuan Liu, Xuefeng Liu, Jingyuan Li, et al.
Medical Science Monitor (2019) Vol. 25, pp. 9280-9289
Open Access | Times Cited: 24
Circulating miR-1246 Targeting UBE2C, TNNI3, TRAIP, UCHL1 Genes and Key Pathways as a Potential Biomarker for Lung Adenocarcinoma: Integrated Biological Network Analysis
Siyuan Huang, Yong-Kai Wei, Satyavani Kaliamurthi, et al.
Journal of Personalized Medicine (2020) Vol. 10, Iss. 4, pp. 162-162
Open Access | Times Cited: 19
The Relationship Between UBE2C and AGGF1 Overexpression and Tumor Angiogenesis in Non-Small Cell Lung Cancer
Yufei Wang, Fan Shi, Run Tao, et al.
Cancer Management and Research (2021) Vol. Volume 13, pp. 5919-5930
Open Access | Times Cited: 17
The activation of the Notch signaling pathway by UBE2C promotes the proliferation and metastasis of hepatocellular carcinoma
Ping Zhan, Yuyan Lu, Jing Lü, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
<p>Circular RNA Circ_0025033 Promotes the Evolvement of Ovarian Cancer Through the Regulation of miR-330-5p/KLK4 Axis</p>
Hailing Cheng, Ning Wang, Jun Tian, et al.
Cancer Management and Research (2020) Vol. Volume 12, pp. 2753-2765
Open Access | Times Cited: 17
Comprehensive analysis of ubiquitin-proteasome system genes related to prognosis and immunosuppression in head and neck squamous cell carcinoma
Juncheng Wang, Jianing Li, Luan Zhang, et al.
Aging (2021) Vol. 13, Iss. 16, pp. 20277-20301
Open Access | Times Cited: 16
Identification of potential core genes in esophageal carcinoma using bioinformatics analysis
Xiaojie Yang, Mengyue Tian, Weiguang Zhang, et al.
Medicine (2021) Vol. 100, Iss. 27, pp. e26428-e26428
Open Access | Times Cited: 15
miR-548c-3p targets TRIM22 to attenuate the Peg–IFN–α therapeutic efficacy in HBeAg-positive patients with chronic hepatitis B
Ni Lin, Long Wang, Zhaopei Guo, et al.
Antiviral Research (2023) Vol. 213, pp. 105584-105584
Closed Access | Times Cited: 6
MicroRNA-32 and MicroRNA-548a Promote the Drug Sensitivity of Non-Small Cell Lung Cancer Cells to Cisplatin by Targeting ROBO1 and Inhibiting the Activation of Wnt/β-Catenin Axis
Jian Zheng, Xiaoxi Li, Cunwei Cai, et al.
Cancer Management and Research (2021) Vol. Volume 13, pp. 3005-3016
Open Access | Times Cited: 13
Derlin‐1 exhibits oncogenic activities and indicates an unfavorable prognosis in breast cancer
Jinsheng Zeng, Qiu‐Hong Tian, Zhimin Zeng, et al.
Cell Biology International (2019) Vol. 44, Iss. 2, pp. 593-602
Closed Access | Times Cited: 12
Overexpressing PTTG family genes predict poor prognosis in kidney renal clear cell carcinoma
Yonghui Gui, Xueni Liu, Chao Wang, et al.
World Journal of Surgical Oncology (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top